Closing the gap between clinical trials and practice: NOACs for atrial fibrillation

In this Cardiovascular Grand Rounds presentation, Peter A. Noseworthy, M.D., a cardiac electrophysiologist at Mayo Clinic's campus in Rochester, Minnesota, discusses the use of observational data to close the gap between clinical trials and clinical practice, specifically related to the use of nonvitamin K oral anticoagulants (NOACs) for the prevention of cardioembolic stroke in patients with atrial fibrillation.

For more information on NOACs for atrial fibrillation and the Mayo Clinic Heart Rhythm Clinic, visit here.

Related Presenters

Related Videos